These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 2743317)
1. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Ciocca DR; Puy LA; Fasoli LC Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317 [TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361 [TBL] [Abstract][Full Text] [Related]
3. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma. McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018 [TBL] [Abstract][Full Text] [Related]
4. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues. Bur M; Shiraki W; Masood S Mod Pathol; 1993 Jul; 6(4):469-72. PubMed ID: 8415594 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and progesterone receptors in uterine sarcomas. Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088 [TBL] [Abstract][Full Text] [Related]
6. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363 [TBL] [Abstract][Full Text] [Related]
7. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
8. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice. Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409 [TBL] [Abstract][Full Text] [Related]
9. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma]. Hatae M; Yagi Y Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151 [TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Su JM; Hsu HK; Chang H; Lin SL; Chang HC; Huang MS; Tseng HH Anticancer Res; 1996; 16(6B):3803-6. PubMed ID: 9042261 [TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone. Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202 [TBL] [Abstract][Full Text] [Related]
13. Presence of an estrogen-regulated protein in endometrial cancer. Sledge GW; Ramzy I; Dressler LG; Dorr FA; Adams DJ; McGuire WL Obstet Gynecol; 1985 Sep; 66(3):423-7. PubMed ID: 3895080 [TBL] [Abstract][Full Text] [Related]
14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues. Oyaizu T; Arita S; Hatano T; Tsubura A J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434 [TBL] [Abstract][Full Text] [Related]
16. Effects of short-term tamoxifen administration in patients with invasive cervical carcinoma. Vargas Roig LM; Lotfi H; Olcese JE; Lo Castro G; Ciocca DR Anticancer Res; 1993; 13(6B):2457-63. PubMed ID: 7907850 [TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of estrogen and progesterone receptors in epidermoid carcinoma of the cervix uteri]. Gougeon E; Peyrat JP; Rohart J; Castelain B; Demaille A Rev Fr Gynecol Obstet; 1988 Jun; 83(6):411-3. PubMed ID: 3406634 [TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173 [TBL] [Abstract][Full Text] [Related]
20. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Brustein S; Fruchter R; Greene GL; Pertschuk LP Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]